Evidence map›Paper›PMID 24075984›Full record

ReviewMolecular phylogenetics and evolution2014

Evolution of glucose utilization: glucokinase and glucokinase regulator protein.

David M Irwin, Huanran Tan

Open access · greenAbstract readReview
In one paragraph

Review in Molecular phylogenetics and evolution, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Pigmented paravenous chorioretinal atrophy: Updated scenario.European journal of ophthalmology · 2024
    Review
  6. Article
  7. Functional Inactivation ofInternational journal of molecular sciences · 2021
    Article
  8. Article
  9. Moonlighting Proteins: The Case of the Hexokinases.Frontiers in molecular biosciences · 2021
    Review
  10. Article
  11. Review
  12. Genes · 2019
    Article
  13. Article
  14. Replication of previous genome-wide association studies ofDiabetes, metabolic syndrome and obesity : targets and therapy · 2019
    Article
  15. The Destiny of Glucose from a MicroRNA Perspective.Frontiers in endocrinology · 2018
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

David M IrwinDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada; Banting and Best Diabetes Centre, University of Toronto, Toronto, Canada; Department of Pharmacology, Peking University, Health Sciences Centre, Beijing, China. Electronic address: david.irwin@utoronto.ca.
Huanran Tan
Peking University · CNUniversity of Toronto · CA

Funding

CIHR 109605-1CIHR CCI-109605
6 · The paper itself

Abstract

Glucose is an essential nutrient that must be distributed throughout the body to provide energy to sustain physiological functions. Glucose is delivered to distant tissues via be blood stream, and complex systems have evolved to maintain the levels of glucose within a narrow physiological range. Phosphorylation of glucose, by glucokinase, is an essential component of glucose homeostasis, both from the regulatory and metabolic point-of-view. Here we review the evolution of glucose utilization from the perspective of glucokinase. We discuss the origin of glucokinase, its evolution within the hexokinase gene family, and the evolution of its interacting regulatory partner, glucokinase regulatory protein (GCKR). Evolution of the structure and sequence of both glucokinase and GCKR have been necessary to optimize glucokinase in its role in glucose metabolism.

Indexed as

PhylogenyAnimalsCarrier ProteinsEvolution, MolecularGlucokinaseGlucoseHumansSequence Analysis, DNACarrier ProteinsGlucokinaseglucokinase regulatory proteinGlucoseGlucokinase (GCK)Glucokinase regulatory protein (GCKR)GlucoseHexokinase (HK)Liver

Identifiers

PMID24075984
PMCPMC3897444
OpenAlexW2065143170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.